952650-05-4

Upstream product

• 952650-04-3 6-bromo-1-cyclopropyl-2-formyl-5-hydroxy-1H-indole-3-carboxylic acid ethyl ester 
• 874595-64-9 5-acetoxy-6-bromo-2-bromomethyl-1-cyclopropyl-1H-indole-3-carboxylic acid ethyl ester 
• 945041-42-9 7-bromo-8-(3-chloropropoxy)-5-cyclopropyl-1-[(3-chloro-4-fluoro-phenyl)amino]-5H-pyridazino[4,5-b]indole 
• 144-62-7 oxalic acid 
• 124-40-3 dimethyl amine 
• 945041-40-7 7-bromo-8-(3-chloropropoxy)-5-cyclopropyl-1,2-dihydro-5H-pyridazino[4,5-b]indol-1-one 
• 945041-39-4 6-bromo-1-cyclopropyl-2-formyl-5-(3-chloropropoxy)-1H-indol-3-carboxylic acid ethyl ester 

Relevant academic research and scientific papers

Vaginitis treating compound and use thereof (by machine translation)

The invention relates to a compound for treating vaginitis and application thereof. The structure of the compound is as shown in the specification, wherein n is any integer from 2 to 6; R1=3-CL, 4-F; 4-CBr3, or 3,4-II-Br; R2 is as shown in the specification. The compound provided by the invention can remarkably inhibit common strains in vaginitis, therefore has significance in clinic practice, and is expected to be developed into a novel medicine for effectively treat vaginitis.